Liu Hong, Zhao Yang, Xie An, Kim Tae-Yun, Terentyeva Radmila, Liu Man, Shi Guangbin, Feng Feng, Choi Bum-Rak, Terentyev Dmitry, Hamilton Shanna, Dudley Samuel C
Division of Cardiology, Department of Medicine, Lillehei Heart Institute, University of Minnesota Twin Cities, Minneapolis, Minnesota, USA.
Division of Cardiology, Lanzhou University Second Hospital, Lanzhou University, Lanzhou, China.
JACC Basic Transl Sci. 2021 Jan 20;6(1):42-52. doi: 10.1016/j.jacbts.2020.11.002. eCollection 2021 Jan.
Diabetes mellitus (DM) is associated with increased arrhythmia. Type 2 DM (T2DM) mice showed prolonged QT interval and increased ventricular arrhythmic inducibility, accompanied by elevated cardiac interleukin (IL)-1β, increased mitochondrial reactive oxygen species (mitoROS), and oxidation of the sarcoplasmic reticulum (SR) Ca release channel (ryanodine receptor 2 [RyR2]). Inhibiting IL-1β and mitoROS reduced RyR2 oxidation and the ventricular arrhythmia in DM. Inhibiting SR Ca2 leak by stabilizing the oxidized RyR2 channel reversed the diabetic arrhythmic risk. In conclusion, cardiac IL-1β mediated the DM-associated arrhythmia through mitoROS generation that enhances SR Ca leak. The mechanistic link between inflammation and arrhythmias provides new therapeutic options.
糖尿病(DM)与心律失常增加有关。2型糖尿病(T2DM)小鼠表现出QT间期延长和室性心律失常诱导性增加,同时伴有心脏白细胞介素(IL)-1β升高、线粒体活性氧(mitoROS)增加以及肌浆网(SR)钙释放通道(雷诺丁受体2 [RyR2])氧化。抑制IL-1β和mitoROS可减少DM中RyR2氧化和室性心律失常。通过稳定氧化的RyR2通道抑制SR Ca2+泄漏可逆转糖尿病心律失常风险。总之,心脏IL-1β通过产生mitoROS介导DM相关心律失常,mitoROS会增强SR钙泄漏。炎症与心律失常之间的机制联系提供了新的治疗选择。